Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
Most drugs used for the treatment of depression, anxiety and related disorders have low absorption, high metabolism, low brain targeting and/or low water solubility, which can make it hard to formulate them at high strength and can also lead to decreased bioavailability. Incorporating these drugs in...
Saved in:
Main Authors: | Patrícia C. Pires (Author), Ana Cláudia Paiva-Santos (Author), Francisco Veiga (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
by: Maria Daniela Ferreira, et al.
Published: (2023) -
Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
by: Margarida Alberto, et al.
Published: (2022) -
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
by: Patrícia C. Pires, et al.
Published: (2023) -
Topical Nano and Microemulsions for Skin Delivery
by: Christofori M. R. R. Nastiti, et al.
Published: (2017) -
Nano- and Microemulsions in Biomedicine: From Theory to Practice
by: Boris Nikolaev, et al.
Published: (2023)